Education
About Us
Working with TipRanks
Follow Us
Catalyst Pharmaceutical Partners (DE:CN2)
:CN2
Catalyst Pharma (CN2) Ownership Overview
6.01% Insiders
17.90%
Mutual Funds
17.22% Other Institutional Investors
23.98% ETFs
34.90% Public Companies and Individual Investors
The ownership structure of Catalyst Pharma (DE:CN2) stock is a mix of institutional, retail, and individual investors. Approximately 59.10% of the company’s stock is owned by Institutional Investors, 6.01% is owned by Insiders, and 34.90% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 12, 2025 | xxxxxxxxxxxxx | $103649 | |
Jun 10, 2025 | xxxxxxxxxxxxx | $5217197 | |
May 15, 2025 | xxxxxxxxxxxxx | $5775720 | |
Mar 07, 2025 | xxxxxxxxxxxxx | $4894610 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $236340 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $293788 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $393407 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $494821 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,565,508 | Institution | 10.30% | 277,534,375 | |
| 7,064,807 | Institution | 5.79% | 156,040,392 | |
| 5,287,884 | Institution | 4.34% | 116,793,494 | |
| 4,281,702 | Insider | 3.51% | 94,569,952 | |
| 3,422,149 | Institution | 2.81% | 75,585,005 | |
| 2,865,639 | Institution | 2.35% | 63,293,369 | |
| 1,718,128 | Institution | 1.41% | 37,948,293 | |
| 1,598,360 | Institution | 1.31% | 35,302,977 | |
| 1,391,684 | Institution | 1.14% | 30,738,125 | |
| 1,191,682 | Institution | 0.98% | 26,320,680 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,287,884 | Institution | 4.34% | 116,793,494 | |
| 1,718,128 | Institution | 1.41% | 37,948,293 | |
| 1,191,682 | Institution | 0.98% | 26,320,680 | |
| 1,122,154 | Institution | 0.92% | 24,785,015 | |
| 1,117,618 | Institution | 0.92% | 24,684,829 | |
| 959,097 | Institution | 0.79% | 21,183,575 | |
| 763,805 | Institution | 0.63% | 16,870,161 | |
| 742,200 | Institution | 0.61% | 16,392,971 | |
| 692,886 | Institution | 0.57% | 15,303,773 | |
| 634,570 | Institution | 0.52% | 14,015,748 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Catalyst Pharmaceutical Partners (DE:CN2)?
According to the latest TipRanks data, approximately 17.22% of the company's stock is held by institutional investors, 6.01% is held by insiders, and 34.90% is held by retail investors.
What percentage of Catalyst Pharmaceutical Partners (DE:CN2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.22% of Catalyst Pharmaceutical Partners (DE:CN2) stock is held by institutional investors.
What percentage of Catalyst Pharmaceutical Partners (DE:CN2) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.90% of Catalyst Pharmaceutical Partners (DE:CN2) stock is held by retail investors.
Who owns the most shares of Catalyst Pharmaceutical Partners (DE:CN2)?
iShares owns the most shares of Catalyst Pharmaceutical Partners (DE:CN2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.